Ajita Grewal, MD
Ophthalmology · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 6 carriers
- Office
- 1
Offices
1 location
Plans that list them
26 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Grewal’s office at (650) 948-9123 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$402,845
Medicare paid this office $402,845 for 1,545 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 1,206 | $140,977 | $109 |
| Established patient problem focused exam of visual system | 477 | $71,817 | $80 |
| Photography of the retina | 1,226 | $43,523 | $33 |
| Imaging of retina | 829 | $32,417 | $37 |
| Removal of recurring cataract in lens capsule using a laser | 81 | $28,102 | $309 |
See all 12 services
| Established patient complete exam of visual system | 1,206 | $140,977 | $109 |
| Established patient problem focused exam of visual system | 477 | $71,817 | $80 |
| Photography of the retina | 1,226 | $43,523 | $33 |
| Imaging of retina | 829 | $32,417 | $37 |
| Removal of recurring cataract in lens capsule using a laser | 81 | $28,102 | $309 |
| New patient complete exam of visual system | 190 | $24,122 | $127 |
| Imaging of optic nerve | 524 | $23,388 | $33 |
| Exam of visual field with extended testing | 271 | $17,472 | $58 |
| Return visit (30+ min) | 46 | $4,900 | $104 |
| Ultrasound scan of cornea to determine thickness | 264 | $2,599 | $9 |
| Long return visit (40+ min) | 14 | $2,444 | $163 |
| Removal of eyelashes using forceps | 12 | $351 | $20 |
Procedures Medicare counted
| Cataract surgery | 66 | More than 68% of doctors who do this |
Who their Medicare patients are
1,545 Original Medicare patients in 2024. Average age 79 · Women 61% · Health risk score 0.87. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 61% · Coronary heart disease 22% · Diabetes 18% · Cancer 18% · Atrial fibrillation 17% · Chronic kidney disease 14% · Heart failure 10% · Depression 8% · COPD 6% · Stroke 6% · Dementia 4%.
The office billed $637,913, Medicare allowed $548,950 and paid $402,845; for 6,130 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,545 | 6,130 | 79 | 0.87 | $637,913 | $402,845 |
| 2023 | 1,560 | 5,142 | 79 | 0.89 | $568,903 | $347,789 |
| 2022 | 1,384 | 4,367 | 79 | 0.88 | $485,690 | $291,678 |
| 2021 | 1,364 | 3,876 | 78 | 0.86 | $440,340 | $267,712 |
| 2020 | 1,167 | 3,141 | 78 | 0.91 | $383,135 | $234,437 |
| 2019 | 1,052 | 3,006 | 78 | 0.90 | $369,389 | $229,912 |
| 2018 | 995 | 2,839 | 78 | 0.94 | $340,792 | $207,059 |
| 2017 | 939 | 2,456 | 78 | 0.91 | $308,627 | $188,325 |
| 2016 | 866 | 2,147 | 78 | 0.91 | $274,603 | $163,833 |
| 2015 | 849 | 2,376 | 78 | 0.93 | $299,601 | $183,192 |
| 2014 | 832 | 2,337 | 78 | 0.91 | $281,886 | $180,245 |
| 2013 | 896 | 2,233 | 78 | 0.91 | $303,566 | $189,030 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Established patient complete exam of visual system | 1,126 | $126,225 | $106 |
| Established patient problem focused exam of visual system | 444 | $61,554 | $78 |
| Photography of the retina | 927 | $31,344 | $32 |
| New patient complete exam of visual system | 248 | $29,836 | $120 |
| Removal of recurring cataract in lens capsule using a laser | 76 | $26,707 | $297 |
| Imaging of optic nerve | 477 | $21,212 | $33 |
| Imaging of retina | 529 | $20,320 | $37 |
| Exam of visual field with extended testing | 228 | $14,009 | $57 |
| Short return visit (20+ min) | 66 | $4,288 | $65 |
| Ultrasound scan of cornea to determine thickness | 220 | $2,267 | $10 |
| Return visit (30+ min) | 15 | $1,566 | $92 |
| New patient visit (15+ min) | 11 | $356 | $32 |
| Removal of eyelashes using forceps | 12 | $349 | $17 |
2022: 13 services
| Established patient complete exam of visual system | 829 | $91,770 | $103 |
| Established patient problem focused exam of visual system | 374 | $48,928 | $76 |
| New patient complete exam of visual system | 272 | $32,464 | $119 |
| Photography of the retina | 802 | $26,749 | $32 |
| Removal of recurring cataract in lens capsule using a laser | 56 | $21,639 | $305 |
| Imaging of optic nerve | 439 | $18,284 | $32 |
| Imaging of retina | 429 | $16,505 | $36 |
| Exam of visual field with extended testing | 181 | $10,557 | $55 |
| Short return visit (20+ min) | 134 | $9,498 | $71 |
| Long return visit (40+ min) | 19 | $3,096 | $163 |
| Ultrasound scan of cornea to determine thickness | 173 | $1,738 | $10 |
| New patient visit (15+ min) | 23 | $1,275 | $55 |
| New patient visit (30+ min) | 11 | $856 | $78 |
2021: 11 services
| Established patient complete exam of visual system | 744 | $85,102 | $107 |
| Established patient problem focused exam of visual system | 400 | $51,345 | $75 |
| New patient complete exam of visual system | 316 | $36,966 | $117 |
| Photography of the retina | 626 | $22,148 | $34 |
| Removal of recurring cataract in lens capsule using a laser | 51 | $17,981 | $305 |
| Imaging of optic nerve | 372 | $15,439 | $33 |
| Imaging of retina | 334 | $13,587 | $38 |
| Exam of visual field with extended testing | 177 | $10,550 | $57 |
| Short return visit (20+ min) | 121 | $8,280 | $68 |
| New patient visit (15+ min) | 38 | $1,918 | $50 |
| Ultrasound scan of cornea to determine thickness | 165 | $1,676 | $10 |
2020: 14 services
| Established patient complete exam of visual system | 539 | $56,835 | $102 |
| New patient complete exam of visual system | 322 | $41,349 | $128 |
| Established patient problem focused exam of visual system | 259 | $29,994 | $76 |
| Removal of recurring cataract in lens capsule using a laser | 59 | $22,344 | $310 |
| Photography of the retina | 544 | $21,966 | $40 |
| Imaging of retina | 314 | $12,377 | $39 |
| Imaging of optic nerve | 291 | $12,162 | $35 |
| New patient visit (30+ min) | 98 | $8,693 | $89 |
| Short return visit (20+ min) | 118 | $7,842 | $62 |
| Exam of visual field with extended testing | 122 | $7,454 | $58 |
| New patient visit (60+ min) | 17 | $2,858 | $168 |
| New patient visit (45+ min) | 20 | $2,060 | $103 |
| Ultrasound scan of cornea to determine thickness | 115 | $1,192 | $10 |
| Return visit (30+ min) | 13 | $896 | $69 |
2019: 16 services
| Established patient complete exam of visual system | 606 | $66,072 | $104 |
| Established patient problem focused exam of visual system | 232 | $33,475 | $77 |
| New patient complete exam of visual system | 218 | $25,274 | $116 |
| Photography of the retina | 498 | $23,784 | $46 |
| Removal of recurring cataract in lens capsule using a laser | 54 | $19,265 | $306 |
| Imaging of optic nerve | 285 | $12,481 | $34 |
| Imaging of retina | 240 | $9,588 | $38 |
| New patient visit (60+ min) | 50 | $8,645 | $173 |
| Exam of visual field with extended testing | 118 | $7,492 | $59 |
| Short return visit (20+ min) | 82 | $4,872 | $58 |
| Laser repair to improve eye fluid flow | 14 | $4,077 | $215 |
| New patient visit (30+ min) | 37 | $2,881 | $78 |
| Return visit (30+ min) | 22 | $2,214 | $92 |
| New patient visit (45+ min) | 16 | $2,180 | $136 |
| Long return visit (40+ min) | 20 | $2,049 | $102 |
| Ultrasound scan of cornea to determine thickness | 104 | $1,111 | $10 |
2018: 15 services
| Established patient complete exam of visual system | 575 | $60,989 | $100 |
| Established patient problem focused exam of visual system | 232 | $30,044 | $75 |
| Photography of the retina | 434 | $24,071 | $53 |
| Removal of recurring cataract in lens capsule using a laser | 53 | $18,222 | $304 |
| New patient complete exam of visual system | 158 | $16,881 | $107 |
| Imaging of optic nerve | 287 | $12,147 | $35 |
| Imaging of retina | 181 | $7,662 | $39 |
| Exam of visual field with extended testing | 117 | $7,456 | $60 |
| New patient visit (60+ min) | 43 | $6,219 | $145 |
| Long return visit (40+ min) | 41 | $5,433 | $123 |
| Short return visit (20+ min) | 75 | $4,126 | $55 |
| New patient visit (30+ min) | 53 | $4,078 | $77 |
| Laser repair to improve eye fluid flow | 12 | $2,803 | $216 |
| Return visit (30+ min) | 16 | $1,800 | $90 |
| Ultrasound scan of cornea to determine thickness | 101 | $1,262 | $12 |
2017: 14 services
| Established patient complete exam of visual system | 555 | $56,277 | $97 |
| Established patient problem focused exam of visual system | 238 | $28,273 | $72 |
| Photography of the retina | 369 | $23,124 | $61 |
| New patient complete exam of visual system | 178 | $20,505 | $115 |
| Removal of recurring cataract in lens capsule using a laser | 54 | $18,650 | $301 |
| Imaging of optic nerve | 211 | $8,197 | $35 |
| Exam of visual field with extended testing | 128 | $8,074 | $59 |
| Imaging of retina | 169 | $6,671 | $38 |
| Short return visit (20+ min) | 71 | $3,883 | $54 |
| New patient visit (30+ min) | 40 | $3,254 | $81 |
| Laser repair to improve eye fluid flow | 15 | $3,250 | $203 |
| Long return visit (40+ min) | 17 | $2,152 | $127 |
| Ultrasound scan of cornea to determine thickness | 114 | $1,440 | $12 |
| Return visit (30+ min) | 11 | $1,059 | $96 |
2016: 12 services
| Established patient complete exam of visual system | 537 | $53,430 | $95 |
| Established patient problem focused exam of visual system | 237 | $27,354 | $69 |
| Photography of the retina | 267 | $19,489 | $72 |
| New patient complete exam of visual system | 148 | $16,861 | $114 |
| Removal of recurring cataract in lens capsule using a laser | 31 | $10,283 | $294 |
| Exam of visual field with extended testing | 142 | $8,062 | $54 |
| Imaging of retina | 150 | $6,311 | $40 |
| Imaging of optic nerve | 146 | $5,967 | $39 |
| Imaging of front third of eye | 130 | $3,846 | $29 |
| Short return visit (20+ min) | 63 | $3,520 | $56 |
| New patient visit (30+ min) | 19 | $1,586 | $83 |
| Long return visit (40+ min) | 11 | $1,207 | $110 |
2015: 14 services
| Established patient complete exam of visual system | 511 | $51,627 | $96 |
| Established patient problem focused exam of visual system | 245 | $30,026 | $69 |
| Photography of the retina | 363 | $27,956 | $74 |
| New patient complete exam of visual system | 143 | $15,994 | $112 |
| Removal of recurring cataract in lens capsule using a laser | 34 | $12,097 | $288 |
| Imaging of retina | 224 | $9,825 | $41 |
| Laser repair to improve eye fluid flow | 25 | $9,666 | $312 |
| Exam of visual field with extended testing | 126 | $7,683 | $58 |
| Imaging of optic nerve | 138 | $5,584 | $40 |
| Short return visit (20+ min) | 60 | $3,164 | $53 |
| Imaging of front third of eye | 77 | $2,374 | $31 |
| Long return visit (40+ min) | 17 | $1,885 | $111 |
| New patient visit (30+ min) | 19 | $1,334 | $70 |
| Ultrasound scan of cornea to determine thickness | 48 | $493 | $10 |
2014: 13 services
| Established patient complete exam of visual system | 522 | $56,540 | $101 |
| Established patient problem focused exam of visual system | 278 | $34,160 | $72 |
| Photography of the retina | 352 | $27,880 | $75 |
| New patient complete exam of visual system | 105 | $12,469 | $119 |
| Removal of recurring cataract in lens capsule using a laser | 28 | $9,394 | $303 |
| Imaging of retina | 203 | $9,012 | $41 |
| Exam of visual field with extended testing | 133 | $7,975 | $57 |
| Imaging of optic nerve | 142 | $5,713 | $39 |
| Long return visit (40+ min) | 26 | $3,001 | $111 |
| Short return visit (20+ min) | 37 | $2,070 | $54 |
| New patient visit (60+ min) | 13 | $1,702 | $131 |
| Ultrasound scan of cornea to determine thickness | 105 | $1,299 | $12 |
| New patient visit (30+ min) | 17 | $1,245 | $73 |
2013: 14 services
| Long return visit (40+ min) | 453 | $53,897 | $115 |
| Established patient problem focused exam of visual system | 234 | $28,168 | $71 |
| New patient visit (60+ min) | 172 | $25,313 | $147 |
| Photography of the retina | 229 | $15,969 | $68 |
| Removal of recurring cataract in lens capsule using a laser | 29 | $11,111 | $309 |
| Established patient complete exam of visual system | 119 | $9,955 | $82 |
| Exam of visual field with extended testing | 155 | $9,852 | $59 |
| Return visit (30+ min) | 66 | $6,856 | $91 |
| Imaging of optic nerve | 154 | $6,179 | $38 |
| Imaging of retina | 109 | $4,870 | $42 |
| New patient visit (30+ min) | 43 | $3,940 | $92 |
| New patient complete exam of visual system | 21 | $2,698 | $128 |
| Short return visit (20+ min) | 30 | $1,604 | $53 |
| Ultrasound scan of cornea to determine thickness | 64 | $777 | $12 |
Drugs they prescribed that Part D paid
$198,790
Pharmacies billed $198,790 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,179) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,189 generic and 990 brand-name prescriptions · $198,790 in drug cost · 19 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rocklatan | 71 | $44,404 | $625 |
| Restasis | 13 | $22,288 | $1,714 |
| Latanoprost | 844 | $12,067 | $14 |
| Rhopressa | 14 | $10,435 | $745 |
| Lumigan | 11 | $9,983 | $908 |
See all 20 drugs
| Rocklatan | 71 | $44,404 | $625 |
| Restasis | 13 | $22,288 | $1,714 |
| Latanoprost | 844 | $12,067 | $14 |
| Rhopressa | 14 | $10,435 | $745 |
| Lumigan | 11 | $9,983 | $908 |
| Vyzulta | 16 | $9,798 | $612 |
| Alphagan P | 17 | $8,459 | $498 |
| Simbrinza | 38 | $8,458 | $223 |
| Cyclosporine | 15 | $6,253 | $417 |
| Brimonidine | 277 | $5,639 | $20 |
| Travoprost | 32 | $4,839 | $151 |
| Dorzolamide-Timolol | 255 | $4,750 | $19 |
| Brimonidine Tartrate-Timolol | 47 | $4,393 | $93 |
| Dorzolamide-Timolol | 28 | $4,295 | $153 |
| Timolol Maleate | 134 | $3,191 | $24 |
| Loteprednol Etabonate | 16 | $1,949 | $122 |
| Dorzolamide | 73 | $1,666 | $23 |
| Neomycin-Polymyxin-Dexameth | 123 | $1,364 | $11 |
| Prednisolone Acetate | 24 | $917 | $38 |
| Doxycycline Hyclate | 18 | $363 | $20 |
Year by year
| 2024 | 2,179 | 435 | 0% (0) | 45% | $198,790 |
| 2023 | 1,790 | 378 | 0% (0) | 46% | $207,709 |
| 2022 | 1,637 | 335 | 0% (0) | 51% | $260,281 |
| 2021 | 1,568 | 324 | 0% (0) | 57% | $261,349 |
| 2020 | 1,026 | 289 | 0% (0) | 52% | $185,252 |
| 2019 | 775 | 200 | 0% (0) | 49% | $160,102 |
| 2018 | 681 | 172 | 0% (0) | 58% | $141,203 |
| 2017 | 695 | 172 | 0% (0) | 53% | $125,530 |
| 2016 | 697 | 159 | 0% (0) | 54% | $118,994 |
| 2015 | 694 | 171 | 0% (0) | 55% | $94,067 |
| 2014 | 819 | 186 | 0% (0) | 53% | $87,961 |
| 2013 | 781 | 173 | 0% (0) | 53% | $77,855 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Rocklatan | 48 | $32,425 | $676 |
| Restasis | 18 | $30,615 | $1,701 |
| Latanoprost | 715 | $20,379 | $29 |
| Rhopressa | 23 | $17,378 | $756 |
| Alphagan P | 25 | $14,415 | $577 |
| Combigan | 17 | $12,027 | $707 |
| Travoprost | 38 | $10,047 | $264 |
| Lumigan | 13 | $9,830 | $756 |
| Simbrinza | 30 | $7,093 | $236 |
| Brimonidine | 162 | $6,432 | $40 |
| Brimonidine Tartrate-Timolol | 31 | $6,413 | $207 |
| Dorzolamide-Timolol | 225 | $4,972 | $22 |
| Timolol Maleate | 137 | $3,552 | $26 |
| Loteprednol Etabonate | 18 | $3,146 | $175 |
| Dorzolamide-Timolol | 21 | $2,851 | $136 |
| Dorzolamide | 76 | $2,510 | $33 |
| Neomycin-Polymyxin-Dexameth | 73 | $892 | $12 |
| Levobunolol | 18 | $661 | $37 |
| Prednisolone Acetate | 19 | $661 | $35 |
| Tobramycin-Dexamethasone | 13 | $537 | $41 |
2022: 19 drugs
| Restasis | 20 | $36,091 | $1,805 |
| Rocklatan | 50 | $35,945 | $719 |
| Alphagan P | 59 | $24,816 | $421 |
| Latanoprost | 642 | $18,652 | $29 |
| Combigan | 34 | $18,491 | $544 |
| Lumigan | 32 | $18,267 | $571 |
| Rhopressa | 20 | $16,032 | $802 |
| Travoprost | 55 | $15,636 | $284 |
| Simbrinza | 37 | $9,235 | $250 |
| Brimonidine | 85 | $7,306 | $86 |
| Timolol Maleate | 137 | $6,587 | $48 |
| Brimonidine Tartrate-Timolol | 21 | $5,886 | $280 |
| Dorzolamide-Timolol | 171 | $4,441 | $26 |
| Loteprednol Etabonate | 17 | $2,648 | $156 |
| Dorzolamide | 62 | $2,215 | $36 |
| Levobunolol | 28 | $818 | $29 |
| Prednisolone Acetate | 14 | $630 | $45 |
| Neomycin-Polymyxin-Dexameth | 37 | $515 | $14 |
| Erythromycin | 13 | $140 | $11 |
2021: 18 drugs
| Restasis | 31 | $41,130 | $1,327 |
| Rocklatan | 43 | $28,886 | $672 |
| Combigan | 60 | $26,238 | $437 |
| Travoprost | 73 | $25,294 | $346 |
| Latanoprost | 599 | $20,001 | $33 |
| Lumigan | 34 | $18,749 | $551 |
| Alphagan P | 63 | $17,651 | $280 |
| Rhopressa | 23 | $13,387 | $582 |
| Simbrinza | 42 | $12,110 | $288 |
| Dorzolamide-Timolol | 174 | $6,782 | $39 |
| Brimonidine | 72 | $6,686 | $93 |
| Timolol Maleate | 90 | $6,071 | $67 |
| Dorzolamide-Timolol | 16 | $1,918 | $120 |
| Dorzolamide | 48 | $1,812 | $38 |
| Pilocarpine | 13 | $805 | $62 |
| Neomycin-Polymyxin-Dexameth | 49 | $694 | $14 |
| Prednisolone Acetate | 11 | $520 | $47 |
| Erythromycin | 16 | $188 | $12 |
2020: 19 drugs
| Combigan | 63 | $28,479 | $452 |
| Lumigan | 38 | $21,019 | $553 |
| Restasis | 25 | $19,902 | $796 |
| Rocklatan | 26 | $19,280 | $742 |
| Travoprost | 50 | $15,161 | $303 |
| Latanoprost | 338 | $10,474 | $31 |
| Rhopressa | 12 | $7,414 | $618 |
| Simbrinza | 41 | $7,291 | $178 |
| Alphagan P | 27 | $6,783 | $251 |
| Dorzolamide-Timolol | 94 | $4,854 | $52 |
| Lotemax | 11 | $3,333 | $303 |
| Brimonidine | 25 | $2,908 | $116 |
| Timolol Maleate | 47 | $2,337 | $50 |
| Dorzolamide | 36 | $1,745 | $48 |
| Dorzolamide-Timolol | 12 | $1,428 | $119 |
| Pilocarpine | 14 | $1,003 | $72 |
| Neomycin-Polymyxin-Dexameth | 58 | $929 | $16 |
| Olopatadine | 11 | $371 | $34 |
| Erythromycin | 12 | $127 | $11 |
2019: 13 drugs
| Travatan Z | 45 | $22,836 | $507 |
| Combigan | 52 | $22,488 | $432 |
| Lumigan | 46 | $19,834 | $431 |
| Restasis | 15 | $14,799 | $987 |
| Rhopressa | 26 | $10,405 | $400 |
| Latanoprost | 270 | $8,026 | $30 |
| Alphagan P | 11 | $4,804 | $437 |
| Dorzolamide-Timolol | 58 | $4,062 | $70 |
| Brimonidine | 24 | $3,626 | $151 |
| Dorzolamide | 38 | $2,128 | $56 |
| Pilocarpine | 13 | $1,771 | $136 |
| Timolol Maleate | 18 | $986 | $55 |
| Neomycin-Polymyxin-Dexameth | 27 | $433 | $16 |
2018: 15 drugs
| Travatan Z | 54 | $23,906 | $443 |
| Combigan | 47 | $21,214 | $451 |
| Restasis | 18 | $17,699 | $983 |
| Lumigan | 38 | $14,870 | $391 |
| Latanoprost | 233 | $8,039 | $35 |
| Alphagan P | 23 | $7,396 | $322 |
| Azopt | 12 | $4,863 | $405 |
| Brimonidine | 16 | $3,583 | $224 |
| Simbrinza | 14 | $3,559 | $254 |
| Timolol Maleate | 24 | $3,007 | $125 |
| Cosopt Pf | 11 | $2,413 | $219 |
| Dorzolamide-Timolol | 24 | $1,041 | $43 |
| Dorzolamide | 26 | $815 | $31 |
| Doxycycline Hyclate | 14 | $648 | $46 |
| Neomycin-Polymyxin-Dexameth | 19 | $256 | $13 |
2017: 16 drugs
| Travatan Z | 65 | $24,086 | $371 |
| Restasis | 22 | $16,922 | $769 |
| Lumigan | 42 | $14,843 | $353 |
| Alphagan P | 43 | $10,537 | $245 |
| Azasite | 25 | $9,554 | $382 |
| Combigan | 17 | $8,379 | $493 |
| Latanoprost | 201 | $6,053 | $30 |
| Azopt | 15 | $4,551 | $303 |
| Lotemax | 11 | $3,778 | $343 |
| Timolol Maleate | 34 | $3,044 | $90 |
| Brimonidine | 11 | $2,423 | $220 |
| Simbrinza | 11 | $2,178 | $198 |
| Dorzolamide-Timolol | 44 | $1,528 | $35 |
| Dorzolamide | 42 | $1,285 | $31 |
| Sulfacetamide | 11 | $396 | $36 |
| Neomycin-Polymyxin-Dexameth | 16 | $167 | $10 |
2016: 14 drugs
| Travatan Z | 73 | $24,890 | $341 |
| Restasis | 26 | $20,960 | $806 |
| Lumigan | 57 | $19,023 | $334 |
| Alphagan P | 29 | $8,103 | $279 |
| Azopt | 19 | $7,410 | $390 |
| Combigan | 16 | $7,115 | $445 |
| Azasite | 19 | $6,125 | $322 |
| Latanoprost | 193 | $4,731 | $25 |
| Simbrinza | 15 | $2,420 | $161 |
| Brimonidine | 16 | $2,264 | $141 |
| Timolol Maleate | 48 | $1,690 | $35 |
| Dorzolamide-Timolol | 44 | $1,395 | $32 |
| Dorzolamide | 49 | $1,214 | $25 |
| Neomycin-Polymyxin-Dexameth | 18 | $336 | $19 |
2015: 15 drugs
| Restasis | 30 | $17,789 | $593 |
| Lumigan | 63 | $17,345 | $275 |
| Travatan Z | 59 | $13,811 | $234 |
| Azopt | 31 | $8,601 | $277 |
| Combigan | 24 | $6,427 | $268 |
| Alphagan P | 13 | $4,572 | $352 |
| Azasite | 15 | $3,755 | $250 |
| Latanoprost | 208 | $3,442 | $17 |
| Lotemax | 11 | $2,081 | $189 |
| Timolol Maleate | 45 | $2,009 | $45 |
| Simbrinza | 12 | $1,919 | $160 |
| Brimonidine | 12 | $1,826 | $152 |
| Dorzolamide-Timolol | 56 | $1,488 | $27 |
| Neomycin-Polymyxin-Dexameth | 35 | $570 | $16 |
| Dorzolamide | 21 | $480 | $23 |
2014: 14 drugs
| Lumigan | 73 | $15,009 | $206 |
| Travatan Z | 64 | $12,868 | $201 |
| Restasis | 27 | $11,282 | $418 |
| Azopt | 36 | $6,973 | $194 |
| Alphagan P | 18 | $5,856 | $325 |
| Latanoprost | 244 | $4,794 | $20 |
| Azasite | 16 | $4,524 | $283 |
| Lotemax | 21 | $4,220 | $201 |
| Timolol Maleate | 73 | $3,195 | $44 |
| Combigan | 19 | $2,944 | $155 |
| Dorzolamide-Timolol | 67 | $1,844 | $28 |
| Brimonidine | 12 | $1,691 | $141 |
| Dorzolamide | 26 | $717 | $28 |
| Neomycin-Polymyxin-Dexameth | 34 | $546 | $16 |
2013: 13 drugs
| Lumigan | 73 | $14,081 | $193 |
| Travatan Z | 58 | $11,375 | $196 |
| Restasis | 31 | $10,727 | $346 |
| Alphagan P | 27 | $6,283 | $233 |
| Latanoprost | 227 | $5,675 | $25 |
| Azopt | 17 | $4,246 | $250 |
| Lotemax | 25 | $4,022 | $161 |
| Combigan | 16 | $3,024 | $189 |
| Timolol Maleate | 64 | $2,349 | $37 |
| Dorzolamide-Timolol | 52 | $1,751 | $34 |
| Dorzolamide | 31 | $1,328 | $43 |
| Brimonidine | 12 | $1,062 | $88 |
| Neomycin-Polymyxin-Dexameth | 33 | $667 | $20 |
Money from drug and device companies
$207 in 2025
| 2025 | 3 | 6 | None | $207 |
| 2024 | 3 | 5 | None | $304 |
| 2023 | 6 | 7 | None | $370 |
| 2022 | 3 | 3 | None | $67 |
| 2021 | 6 | 12 | None | $240 |
| 2020 | 6 | 8 | None | $148 |
| 2019 | 4 | 21 | None | $770 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Tryptyr | $166 | 4 payments
|
| Thea Pharma | Iyuzeh | $24 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $17 | 1 payment
|
See all 6 published payments
| Alcon Vision | Meals · 2025-12-11 | Tryptyr | $19 |
| Oyster Point Pharma | Meals · 2025-12-04 | Tyrvaya | $17 |
| Alcon Vision | Meals · 2025-11-06 | Rocklatan | $18 |
| Thea Pharma | Meals · 2025-10-03 | Iyuzeh | $24 |
| Alcon Vision | Meals · 2025-09-06 | Tryptyr | $7 |
| Alcon Vision | Meals · 2025-07-23 | Tryptyr | $122 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $304
| Oyster Point Pharma | Tyrvaya | $146 | 2 payments
|
| Dompe US | Oxervate | $131 | 2 payments
|
| Alcon Vision | Rocklatan | $26 | 1 payment
|
2023: $370
| Genentech USA | None | $149 | 1 payment
|
| Bausch & Lomb Americas | Miebo | $130 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $27 | 1 payment
|
| Biotissue Holdings | Prokera | $24 | 1 payment
|
| Alcon Vision | Rocklatan | $21 | 1 payment
|
| Abbvie | Durysta | $20 | 1 payment
|
2022: $67
| Abbvie | Durysta | $24 | 1 payment
|
| Allergan | Vuity | $24 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $19 | 1 payment
|
2021: $240
| Tissuetech | Prokera | $68 | 4 payments
|
| Sun Pharmaceutical Industries | Cequa | $64 | 3 payments
|
| Allergan | Alphagan P | $44 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Infuse | $24 | 1 payment
|
| Aerie Pharmaceuticals | Rhopressa | $21 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $18 | 1 payment
|
2020: $148
| Novartis Pharmaceuticals | Xiidra | $40 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $39 | 2 payments
|
| Aerie Pharmaceuticals | Rhopressa | $21 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Prolensa | $18 | 1 payment
|
| Allergan | Restasis | $15 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $15 | 1 payment
|
2019: $770
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $250 | 1 payment
|
| Aerie Pharmaceuticals | Rhopressa | $242 | 3 payments
|
| Sun Pharmaceutical Industries | Bromsite | $144 | 15 payments
|
| Allergan | Restasis | $134 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1669491486
- Licence
- CA A061389
- Trained
- Duke University School of Medicine, 1995
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 762 Altos Oaks Dr, Los Altos, CA, 94024
- NPI first listed
- 2006-07-19
- NPI last updated
- 2015-06-09
This is when the NPI record was last certified, not a medical board exam.